Evotec AG (EVO) vs Tilray Brands, Inc. (TLRY)
Evotec AG and Tilray Brands, Inc. are both Drug Manufacturers Specialty & Generic companies. Tilray Brands, Inc. is the larger, with a market value of $603.0M against $539.9M — 1.1× the size. Tilray Brands, Inc. grew revenue faster over the last twelve months: 11.5% against 2.15%. Tilray Brands, Inc. has the higher net margin (−13.3% vs −26.2%) and the lower return on invested capital (−2.27% vs 0.00%). Across the 18 metrics below, Tilray Brands, Inc. leads on 10 and Evotec AG on 8.
Valuation
Profitability
| Metric | EVO | TLRY | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 11.42% | 28.45% | 53.94% |
| Operating margin | (21.35%) | (6.88%) | 0.00% |
| Net margin | (26.20%) | (13.26%) | 0.00% |
| Free cash flow margin | 0.00% | (10.77%) | 0.00% |
| Return on equity | 0.00% | (7.87%) | (0.40%) |
| Return on assets | 0.00% | (5.52%) | (3.32%) |
| Return on invested capital | 0.00% | (2.27%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack